Cherokee Health Systems

Cherokee Health Systems

Services:
Other Services
• Treatment for other addiction disorder

Pharmacotherapies

• Nicotine replacement
• Naltrexone (oral)
• Naltrexone (extended-release, injectable)
• Non-nicotine smoking/tobacco cessation
• Acamprosate (Campral®)
• Buprenorphine with naloxone
• Buprenorphine without naloxone
• Medication for mental disorders
• Buprenorphine (extended-release, injectable)
• Disulfiram
• Medications for pre-exposure to prophylaxis

Payment Assistance Available

• Sliding fee scale (fee is based on income and other factors)

Facility Operation (e.g., Private, Public)

• Private non-profit organization

Ancillary Services

• Case management service
• Integrated primary care services
• Transportation assistance
• Mental health services
• Early intervention for HIV

Language Services

• Sign language services for the deaf and hard of hearing

Service Setting (e.g., Outpatient, Residential, Inpatient, etc.)

• Regular outpatient treatment
• Outpatient methadone/buprenorphine or naltrexone treatment
• Outpatient

Type of Alcohol Use Disorder Treatment

• This facility administers/prescribes medication for alcohol use disorder

Recovery Support Services

• Housing services
• Assistance with obtaining social services
• Recovery coach
• Mentoring/peer support

Medical Services

• Hepatitis B (HBV) vaccination
• Hepatitis A (HAV) vaccination

Assessment/Pre-treatment

• Screening for mental disorders
• Comprehensive mental health assessment
• Screening for tobacco use
• Complete medical history/physical exam
• Comprehensive substance use assessment
• Screening for substance use

Testing

• Drug or alcohol urine screening
• STD testing
• TB screening
• Metabolic syndrome monitoring
• Testing for Hepatitis B (HBV)
• HIV testing
• Testing for Hepatitis C (HCV)

Facility Smoking Policy

• Smoking permitted in designated area

External Source of Medications Used for Alcohol Use Disorder Treatment

• No formal relationship with prescribing entity
• In-network prescribing entity

Type of Care

• Substance use treatment
• Treatment for co-occurring substance use plus either serious mental health illness in adults/serious emotional disturbance in children

Type of Opioid Treatment

• Prescribes naltrexone
• Maintenance service with medically supervised withdrawal after stabilization

License/Certification/Accreditation

• State mental health department
• Federally Qualified Health Center
• State Substance use treatment agency

Facility Vaping Policy

• Vaping permitted in designated area

Transitional Services

• Aftercare/continuing care
• Naloxone and overdose education

Treatment Approaches

• Substance use disorder counseling
• Motivational interviewing
• Trauma-related counseling
• Cognitive behavioral therapy
• Brief intervention
• Relapse prevention
• Telemedicine/telehealth therapy

Payment/Insurance/Funding Accepted

• Medicare
• State-financed health insurance plan other than Medicaid
• Cash or self-payment
• Federal, or any government funding for substance use treatment programs
• Federal military insurance (e.g., TRICARE)
• Private health insurance
• Medicaid
• SAMHSA funding/block grants

Gender Accepted

• Female
• Male

Opioid Medications used in Treatment

• Buprenorphine used in Treatment
• Naltrexone used in Treatment

Education and Counseling Services

• Health education services other than HIV/AIDS or hepatitis
• Marital/couples counseling
• Substance use disorder education
• Hepatitis education, counseling, or support
• HIV or AIDS education, counseling, or support
• Individual counseling
• Family counseling
• Group counseling
• Smoking/vaping/tobacco cessation counseling